Role for RhoB and PRK in the suppression of epithelial cell transformation by farnesyltransferase inhibitors.

Abstract:

:Recent genetic investigations have established that RhoB gain-of-function is sufficient to mediate the antitransforming effects of farnesyltransferase inhibitors (FTIs) in H-Ras-transformed fibroblast systems. In this study, we addressed the breadth and mechanism of RhoB action in epithelial cells transformed by oncoproteins which are themselves insensitive to FTI inactivation. Rat intestinal epithelial (RIE) cells transformed by activated K-Ras or Rac1 were highly sensitive to FTI-induced actin reorganization and growth inhibition, despite the inability of FTI to block prenylation of either K-Ras or Rac1. Ectopic expression of the geranylgeranylated RhoB isoform elicited in cells by FTI treatment phenocopied these effects. Analysis of RhoB effector domain mutants pointed to a role for PRK, a Rho effector kinase implicated in the physiological function of RhoB in intracellular receptor trafficking, and these findings were supported further by experiments in a fibroblast system. We propose that FTIs recruit the antioncogenic RhoB protein in the guise of RhoB-GG to interfere with signaling by pro-oncogenic Rho proteins, possibly by sequestering common exchange factors or effectors such as PRK that are important for cell transformation.

journal_name

Oncogene

journal_title

Oncogene

authors

Zeng PY,Rane N,Du W,Chintapalli J,Prendergast GC

doi

10.1038/sj.onc.1206181

subject

Has Abstract

pub_date

2003-02-27 00:00:00

pages

1124-34

issue

8

eissn

0950-9232

issn

1476-5594

pii

1206181

journal_volume

22

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.

    abstract::Smad4 is a critical component in transforming growth factor beta (TGF-beta) signaling and frequently mutated in pancreatic and colorectal cancers. Smad4 has two important functional domains, MH1 and MH2, that are involved in different biological processes. The MH1 domain comprises a DNA binding domain and the MH2 doma...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207219

    authors: Kuang C,Chen Y

    更新日期:2004-02-05 00:00:00

  • Human c-FES is a nuclear tyrosine kinase.

    abstract::FES is a non-receptor protein tyrosine kinase expressed in hematopoietic progenitors and differentiated myeloid cells. It has recently been implicated in granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and erythropoietin signal transduction. To better understand the role played by FES i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yates KE,Lynch MR,Wong SG,Slamon DJ,Gasson JC

    更新日期:1995-03-16 00:00:00

  • Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.

    abstract::Non small cell lung cancer (NSCLC) is the leading cause of cancer deaths in the United States and worldwide. Unfortunately, standard therapies remain inadequate. An increased understanding of the molecular biology of lung cancer biology is required to develop more effective new therapies. In this report, we show that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206817

    authors: Uematsu K,He B,You L,Xu Z,McCormick F,Jablons DM

    更新日期:2003-10-16 00:00:00

  • Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway.

    abstract::Constitutively active HER2/neu activates nuclear factor kappa-B (NF-kappaB) in cells and induces their resistance to apoptotic stimuli such as tumor necrosis factor-alpha (TNF-alpha). Here, we show that integrin-linked kinase (ILK), the crucial signal transducer in the integrin pathway, is involved in HER2/neu-mediate...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207485

    authors: Makino K,Day CP,Wang SC,Li YM,Hung MC

    更新日期:2004-05-06 00:00:00

  • MicroRNAs and chromosomal abnormalities in cancer cells.

    abstract::Over the past five decades, a plethora of nonrandom chromosomal abnormalities have been consistently reported in malignant cells facilitating the identification of cancer-associated protein coding oncogenes and tumor suppressors. The genetic dissection of hot spots for chromosomal abnormalities in the age of the seque...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209910

    authors: Calin GA,Croce CM

    更新日期:2006-10-09 00:00:00

  • E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.

    abstract::E2a/Pbx1 is a fusion oncoprotein resulting from the t(1;19) translocation found in human pre-B acute lymphocytic leukemia and in a small number of acute T-lymphoid and myeloid leukemias. It was previously suggested that E2a/Pbx1 could cooperate with normal or oncogenic signaling pathways to immortalize myeloid and lym...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209777

    authors: Bourette RP,Grasset MF,Mouchiroud G

    更新日期:2007-01-11 00:00:00

  • A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion.

    abstract::Skeletrophin (mindbomb homolog 2 (MIB2)) is a RING (Really Interesting New Gene) finger-dependent ubiquitin ligase, which targets the intracellular region of Notch ligands. A previous immunohistochemical study demonstrated that skeletrophin was downregulated in many melanomas. In the present study, we have identified ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209688

    authors: Takeuchi T,Adachi Y,Sonobe H,Furihata M,Ohtsuki Y

    更新日期:2006-11-09 00:00:00

  • Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.

    abstract::We have identified the mouse telomerase reverse transcriptase component (mTERT) and demonstrate both substantial sequence homology to the human ortholog (hTERT), and the presence of reverse transcriptase and telomerase specific motifs. Furthermore, we show functional interchangeability with hTERT in in vitro telomeras...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201933

    authors: Greenberg RA,Allsopp RC,Chin L,Morin GB,DePinho RA

    更新日期:1998-04-02 00:00:00

  • CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.

    abstract::CD97, a member of the adhesion family of G-protein-coupled receptors (GPCRs), complexes with and potentiates lysophosphatidic acid (LPA) receptor signaling to the downstream effector RHOA. We show here that CD97 was expressed in a majority of thyroid cancers but not normal thyroid epithelium and that the level of CD97...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.301

    authors: Ward Y,Lake R,Martin PL,Killian K,Salerno P,Wang T,Meltzer P,Merino M,Cheng SY,Santoro M,Garcia-Rostan G,Kelly K

    更新日期:2013-05-30 00:00:00

  • Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.

    abstract::E2F transcription factors are important regulators of the cell cycle, and unrestrained activation of E2F-dependent transcription is considered to be an important driver of tumor formation and progression. Although highly expressed in normal skin and skin cancer, the role of the atypical E2Fs, E2F7 and E2F8, in keratin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.251

    authors: Thurlings I,Martínez-López LM,Westendorp B,Zijp M,Kuiper R,Tooten P,Kent LN,Leone G,Vos HJ,Burgering B,de Bruin A

    更新日期:2017-02-09 00:00:00

  • Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice.

    abstract::Functional alterations or loss of tumor-suppressor genes are an important feature of neoplastic progression in humans. The employment of suitable animal model systems would greatly facilitate the detection and manipulation of such genes. We describe here an experimental approach to this problem based on the analysis o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Burns PA,Kemp CJ,Gannon JV,Lane DP,Bremner R,Balmain A

    更新日期:1991-12-01 00:00:00

  • The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors.

    abstract::We have studied the relationship between ras-GAP and G protein coupled receptors in a proliferative setting comprised of NIH3T3 expressing transfected muscarinic receptors (mAChRs). GAP expression plasmids were engineered to encode wild-type GAP, its carboxyl-terminal catalytic domain, a mutant lacking a portion of th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Xu N,McCormick F,Gutkind JS

    更新日期:1994-02-01 00:00:00

  • TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    abstract::Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine with the capability to act as tumour suppressor or tumour promoter depending on the cellular context. TGF-beta receptor type-2 (TGFBR2) is the ligand-binding receptor for all members of the TGF-β family. Data from mouse model experiments demonstrated th...

    journal_title:Oncogene

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/onc.2013.527

    authors: Busch S,Acar A,Magnusson Y,Gregersson P,Rydén L,Landberg G

    更新日期:2015-01-02 00:00:00

  • MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.

    abstract::MicroRNAs (miRNAs) as modulators of gene expression have been described to display both tumor-promoting and tumor-suppressive functions. Although their role has been studied in different tumor types, little is known about how they regulate nuclear factor κB (NF-κB) signaling in breast cancer. Here, we performed an unb...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.571

    authors: Keklikoglou I,Koerner C,Schmidt C,Zhang JD,Heckmann D,Shavinskaya A,Allgayer H,Gückel B,Fehm T,Schneeweiss A,Sahin O,Wiemann S,Tschulena U

    更新日期:2012-09-13 00:00:00

  • A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4.

    abstract::In a previous work we provided preliminary evidence of the existence of a putative tumor suppressor gene region on the distal part of chromosome 4 in gamma-radiation-induced T-cell lymphomas of (C57BL/6J x RF/J) F1 hybrid mice. This region, named as TLSR2 (Thymic Lymphoma Suppressor Region 2), was located centered at ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202009

    authors: Santos J,Herranz M,Pérez de Castro I,Pellicer A,Fernández-Piqueras J

    更新日期:1998-08-20 00:00:00

  • Identification of fyn-encoded proteins in normal human blood cells.

    abstract::We have previously reported that carboxyl terminal truncations of the normal human fyn gene, a member of the src subfamily, can transform immortal mouse fibroblasts to full malignancy. In search of evidence which suggests the possible activation of the human fyn gene, we have screened DNAs and RNAs from a number of hu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kawakami Y,Furue M,Kawakami T

    更新日期:1989-03-01 00:00:00

  • Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.

    abstract::Pax3 is an evolutionarily conserved transcription factor that plays a major role in a variety of developmental processes. Mutations in Pax3 lead to severe malformations as seen in human Waardenburg syndrome and in the Splotch mutant mice. The transcriptional activity of Pax3 was recently shown to be repressed by Daxx ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204063

    authors: Lehembre F,Müller S,Pandolfi PP,Dejean A

    更新日期:2001-01-04 00:00:00

  • Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.

    abstract::The 2;13 chromosomal translocation occurs in most cases of the cancer alveolar rhabdomyosarcoma (ARMS), and juxtaposes the genes encoding the PAX3 and FKHR transcription factors. The resulting chimeric protein PAX3-FKHR is a potent transcriptional activator, and is hypothesized to function as a dominant acting oncogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207850

    authors: Xia SJ,Barr FG

    更新日期:2004-09-09 00:00:00

  • Bcr-Abl induces autocrine IGF-1 signaling.

    abstract::Bcr-Abl oncogene is responsible for the initial phase of chronic myelogenous leukemia (CML), which is effectively treated by the Bcr-Abl inhibitor imatinib. Over time patients become resistant to treatment and progress to blast crisis, an event that is driven by additional genetic and epigenetic aberrations. Recently,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.8

    authors: Lakshmikuttyamma A,Pastural E,Takahashi N,Sawada K,Sheridan DP,DeCoteau JF,Geyer CR

    更新日期:2008-06-19 00:00:00

  • The role of Gads in hematopoietic cell signalling.

    abstract::Gads is a member of the family of SH2 and SH3 domain containing adaptor proteins that is expressed specifically in hematopoietic cells and functions in the coordination of tyrosine kinase mediated signal transduction. Gads plays a critical role in signalling from the T cell receptor by promoting the formation of a com...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1204771

    authors: Liu SK,Berry DM,McGlade CJ

    更新日期:2001-10-01 00:00:00

  • Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1.

    abstract::Checkpoint protein Chk1 has been identified as an Hsp90 client. Treatment with 100 nM geldanamycin (GM) for 24 h markedly reduced the Chk1 amount in Jurkat and ML-1 leukemia cell lines. Because Chk1 plays a central role in G2 checkpoint, we added GM to G2-arrested Jurkat and HL-60 cells pretreated with 50 nM doxorubic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210978

    authors: Sugimoto K,Sasaki M,Isobe Y,Tsutsui M,Suto H,Ando J,Tamayose K,Ando M,Oshimi K

    更新日期:2008-05-15 00:00:00

  • Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14.

    abstract::We have previously reported on the identification of a cDNA (placenta growth factor, PlGF) coding for a novel angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). Biochemical and functional characterization of PlGF derived from t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maglione D,Guerriero V,Viglietto G,Ferraro MG,Aprelikova O,Alitalo K,Del Vecchio S,Lei KJ,Chou JY,Persico MG

    更新日期:1993-04-01 00:00:00

  • Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.

    abstract::Low oxygen tension (hypoxia) is a common feature of solid tumors and stimulates the expressions of a variety of genes including those related to angiogenesis, apoptosis and endoplasmic reticulum (ER) stress response. Here we show a close correlation between metastatic potential and the resistance to hypoxia- and ER st...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209128

    authors: Koshikawa N,Maejima C,Miyazaki K,Nakagawara A,Takenaga K

    更新日期:2006-02-09 00:00:00

  • Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.

    abstract::The breast cancer-associated protein, BARD1, colocalizes with BRCA1 in nuclear foci in the S phase and after DNA damage, and the two proteins form a stable heterodimer implicated in DNA repair, protein ubiquitination, and control of mRNA processing. BARD1 has a BRCA1-independent proapoptotic activity; however, little ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207302

    authors: Rodriguez JA,Schüchner S,Au WW,Fabbro M,Henderson BR

    更新日期:2004-03-11 00:00:00

  • Human T-cell leukemia virus type 1 Tax attenuates gamma-irradiation-induced apoptosis through physical interaction with Chk2.

    abstract::Checkpoint kinase 2 (Chk2) is known to mediate diverse cellular responses to genotoxic stress. The fundamental role of Chk2 is to regulate the network of genome-surveillance pathways that coordinate cell-cycle progression with DNA repair and cell survival or death. Defects in Chk2 contribute to the development of both...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209059

    authors: Park HU,Jeong SJ,Jeong JH,Chung JH,Brady JN

    更新日期:2006-01-19 00:00:00

  • DNA: leukemia's secret weapon of bone mass destruction.

    abstract::Interaction of tumour cells with their microenvironment impacts on all aspects of cancer, ranging from development through to treatment response. In this issue, Dvorak and colleagues(1) reveal a novel tumour/microenvironment relationship that may drive leukemia pathogenesis. Specifically, they find that leukemic cells...

    journal_title:Oncogene

    pub_type: 评论,杂志文章

    doi:10.1038/onc.2012.639

    authors: Tait S

    更新日期:2013-10-31 00:00:00

  • NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

    abstract::The recent years have seen a significant shift in the expectations for the therapeutic management of disseminated melanoma. The clinical success of BRAF targeted therapy suggests that long-term disease control may one day be a reality for genetically defined subgroups of melanoma patients. Despite this progress, few a...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.453

    authors: Fedorenko IV,Gibney GT,Smalley KS

    更新日期:2013-06-20 00:00:00

  • Expression of beta-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin.

    abstract::In order to assess the functional contribution of the human c-myc promoter region in the expression of the c-myc gene, transgenic mouse lines containing a bacterial lac Z gene encoding beta-galactosidase under the control of the human c-myc protooncogene promoter were generated. Transgenic mouse embryos heterozygous f...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Jones DE Jr,Cui DM,Miller DM

    更新日期:1995-06-15 00:00:00

  • Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer.

    abstract::Metastasis is the chief cause of mortality from cancer, but the mechanisms leading to metastasis are poorly understood. We used a proteomics approach to screen for metastasis-associated proteins and found that collapsin response mediator protein-4 (CRMP4) expression was inversely associated with the lymph node metasta...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.213

    authors: Gao X,Pang J,Li LY,Liu WP,Di JM,Sun QP,Fang YQ,Liu XP,Pu XY,He D,Li MT,Su ZL,Li BY

    更新日期:2010-08-12 00:00:00

  • Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.

    abstract::The Crk II adaptor protein encodes an SH2/SH3-domain containing adaptor protein with an SH2-SH3-SH3 domain structure that transmits signals from tyrosine kinases. The two SH3 domains are separated by a 54 amino acid linker region, whose length is highly conserved in xenopus, chicken, and mamalian Crk II proteins. To g...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204173

    authors: Zvara A,Fajardo JE,Escalante M,Cotton G,Muir T,Kirsch KH,Birge RB

    更新日期:2001-02-22 00:00:00